Kovalenko N N, Kogosova L S, Tsygankova L M, Chernushenko E F, Gumeniuk N I
Lik Sprava. 1993 Jul(7):73-6.
64 patients with infectious-allergic bronchial asthma (IABA) were examined. 20 of them were co-administered paspat, 24 patients additionally received prodigiosan, 20 patients constituted control group and were given conventional treatment. Patients of all the groups were comparable in age, state of immunological reactivity of the body and severity of the disease. Immunomodulatory effect of the drugs, mainly of paspat, not only resulted in normalization of functional properties of granulocytes but also promoted liquidation of quantitative and functional IABA-conditioned immunodeficiency on the part of T- and B-lymphocytes, thus increasing effectiveness of the treatment in the whole.
对64例感染性过敏性支气管哮喘（IABA）患者进行了检查。其中20例联合使用了帕斯巴特，24例额外接受了灵菌红素，20例组成对照组并接受常规治疗。所有组的患者在年龄、机体免疫反应状态和疾病严重程度方面具有可比性。这些药物（主要是帕斯巴特）的免疫调节作用不仅使粒细胞的功能特性恢复正常，还促进了T淋巴细胞和B淋巴细胞方面因IABA导致的定量和功能性免疫缺陷的消除，从而提高了整体治疗效果。
